microdosing glp 1 for menopause THE PCCA BLOG Jill - More and more

Diabetes 58 , 13121320 (2009)

For individuals managing weight or metabolic health while breastfeeding, this decision requires balancing treatment goals with infant safety

What is already known on this topic Concerns exist about a potential association between glucagon-like peptide-1 receptor (GLP-1) agonists and suicidality This has prompted regulatory agencies to conduct comprehensive reviews of this drug class Observational studies investigating this safety concern remain inconclusive

"One concern is whether we're seeing clinically meaningful personalization or changes that primarily allow compounded products to remain on the market," DiStefano said